The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1470
ISSUE1470
June 8, 2015
Recombinant Human Parathyroid Hormone (Natpara)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Recombinant Human Parathyroid Hormone (Natpara)
June 8, 2015 (Issue: 1470)
The FDA has approved a subcutaneously injected
formulation of recombinant human parathyroid
hormone (Natpara – NPS) as an adjunct to calcium
and vitamin D to control hypocalcemia in adults
with hypoparathyroidism. Natpara is an 84-amino
acid...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.